NiKang Therapeutics’ US$200 Million Equity Financing

Sidley Austin LLP advised the lead investors on the deal.HBM Healthcare Investments, Cormorant Asset Management, and Octagon Capital Advisors, with participation from a syndicate of other leading…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here